Stock Analysis

Nanofilm Technologies International First Half 2025 Earnings: EPS: S$0.002 (vs S$0.006 loss in 1H 2024)

SGX:MZH 1 Year Share Price vs Fair Value
SGX:MZH 1 Year Share Price vs Fair Value
Explore Nanofilm Technologies International's Fair Values from the Community and select yours
Advertisement

Nanofilm Technologies International (SGX:MZH) First Half 2025 Results

Key Financial Results

  • Revenue: S$107.2m (up 30% from 1H 2024).
  • Net income: S$1.61m (up from S$3.74m loss in 1H 2024).
  • Profit margin: 1.5% (up from net loss in 1H 2024). The move to profitability was driven by higher revenue.
  • EPS: S$0.002 (up from S$0.006 loss in 1H 2024).
earnings-and-revenue-growth
SGX:MZH Earnings and Revenue Growth August 15th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Nanofilm Technologies International Earnings Insights

Looking ahead, revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in Asia.

Performance of the market in Singapore.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. See our latest analysis on Nanofilm Technologies International's balance sheet health.

Valuation is complex, but we're here to simplify it.

Discover if Nanofilm Technologies International might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.